The Impact of Prophylactic Post-Chemotherapy G-CSF on the Relapse Rates in Patients with Acute Myeloid Leukemia: A Meta-Analysis

被引：4
作者：
Bordbar, Mohammadreza [1 ]
Hosseini-Bensenjan, Mahnaz [1 ]
Sayadi, Mehrab [2 ]
Zekavat, Omidreza [1 ]
Bordbar, Shayan [3 ]
Nozari, Farnoosh [1 ]
Haghpanah, Sezaneh [1 ]
机构：
[1] Shiraz Univ Med Sci, Hematol Res Ctr, Shiraz, Iran
[2] Shiraz Univ Med Sci, Cardiovasc Res Ctr, Shiraz, Iran
[3] Shiraz Univ Med Sci, Student Res Ctr, Shiraz, Iran
来源：
CANCER INVESTIGATION | 2024年 / 42卷 / 06期
关键词：
Acute myeloid leukemia; granulocyte colony-stimulating factor; relapse; survival; meta-analysis; COLONY-STIMULATING FACTOR; HEMATOPOIETIC GROWTH-FACTORS; ACUTE MYELOGENOUS LEUKEMIA; PLACEBO-CONTROLLED TRIAL; INDUCTION CHEMOTHERAPY; FEBRILE NEUTROPENIA; RANDOMIZED-TRIAL; ELDERLY-PATIENTS; DOUBLE-BLIND; CELL-CYCLE;
D O I：
10.1080/07357907.2024.2352454
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This meta-analysis evaluated the impact of prophylactic post-chemotherapy granulocyte colony-stimulating factor (G-CSF) in patients with acute myeloid leukemia (AML). Overall, the relapse rate, overall survival, event-free survival, and mortality rate were similar in G-CSF (+) compared to G-CSF (-) patients. However, the relative risk (RR) of relapse was higher in children and in secondary AML patients who were treated with G-CSF compared to the G-CSF (-) group [RR, 95% confidence interval: 1.26, 1.04-1.52, and 1.12 (1.02-1.24)]. Treatment with post-chemotherapy G-CSF should be prescribed with caution in pediatric patients with AML and secondary AML as possibly increasing the relapse risk.
引用
收藏
页码：452 / 468
页数：17
相关论文
共 50 条
[41]   Impact of antibacterial prophylaxis during reinduction chemotherapy for relapse/refractory acute myeloid leukemia [J].
Ganti, Beejal R. ;
Marini, Bernard L. ;
Nagel, Jerod ;
Bixby, Dale ;
Perissinotti, Anthony J. .
SUPPORTIVE CARE IN CANCER, 2017, 25 (02) :541-547
[42]   Impact of antibacterial prophylaxis during reinduction chemotherapy for relapse/refractory acute myeloid leukemia [J].
Beejal R. Ganti ;
Bernard L. Marini ;
Jerod Nagel ;
Dale Bixby ;
Anthony J. Perissinotti .
Supportive Care in Cancer, 2017, 25 :541-547
[43]   Impact of prophylactic intrathecal chemotherapy on CNS relapse rates in AML patients presenting with hyperleukocytosis [J].
Reid, Justin H. ;
Perissinotti, Anthony J. ;
Benitez, Lydia ;
Bixby, Dale L. ;
Burke, Patrick ;
Pettit, Kristen ;
Marini, Bernard L. .
LEUKEMIA & LYMPHOMA, 2020, 61 (04) :862-868
[44]   Effectiveness and safety of primary prophylaxis with G-CSF after induction therapy for acute myeloid leukemia: a systematic review and meta-analysis of the clinical practice guidelines for the use of G-CSF 2022 from the Japan society of clinical oncology [J].
Tomoya Maeda ;
Yuho Najima ;
Yutaro Kamiyama ;
Shinji Nakao ;
Yukinori Ozaki ;
Hiroshi Nishio ;
Kenji Tsuchihashi ;
Eiki Ichihara ;
Yuji Miumra ;
Makoto Endo ;
Dai Maruyama ;
Tatsuhiro Yoshinami ;
Nobuyuki Susumu ;
Munetaka Takekuma ;
Takashi Motohashi ;
Mamoru Ito ;
Eishi Baba ;
Nobuaki Ochi ;
Toshio Kubo ;
Keita Uchino ;
Takahiro Kimura ;
Shinobu Tamura ;
Hitomi Nishimoto ;
Yasuhisa Kato ;
Atsushi Sato ;
Toshimi Takano ;
Shingo Yano .
International Journal of Clinical Oncology, 2024, 29 :535-544
[45]   FLAG (fludarabine, cytosine arabinoside, G-CSF) for refractory and relapsed acute myeloid leukemia [J].
Huhmann, IM ;
Watzke, HH ;
Geissler, K ;
Gisslinger, H ;
Jager, U ;
Knobl, P ;
Pabinger, I ;
Korninger, L ;
Mannhalter, C ;
Mitterbauer, G ;
Schwarzinger, I ;
Kalhs, P ;
Haas, OA ;
Lechner, K .
ANNALS OF HEMATOLOGY, 1996, 73 (06) :265-271
[46]   Meta-analysis of autologous bone marrow transplantation versus chemotherapy in adult patients with acute myeloid leukemia in first remission [J].
Levi, I ;
Grotto, I ;
Yerushalmi, R ;
Ben-Bassat, I ;
Shpilberg, O .
LEUKEMIA RESEARCH, 2004, 28 (06) :605-612
[47]   INDUCTION OF GRANULOCYTIC MATURATION IN ACUTE MYELOID-LEUKEMIA BY G-CSF AND RETINOIC ACID [J].
SANTINI, V ;
COLOMBAT, P ;
DELWEL, R ;
VANGURP, R ;
TOUW, I ;
LOWENBERG, B .
LEUKEMIA RESEARCH, 1991, 15 (05) :341-350
[48]   Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of poor risk acute myeloid leukemia [J].
Montillo, M ;
Mirto, S ;
Petti, MC ;
Latagliata, R ;
Magrin, S ;
Pinto, A ;
Zagonel, V ;
Mele, G ;
Tedeschi, A ;
Ferrara, F .
AMERICAN JOURNAL OF HEMATOLOGY, 1998, 58 (02) :105-109
[49]   Systematic review and meta-analysis: Prognostic impact of time from diagnosis to treatment in patients with acute myeloid leukemia [J].
Franco, Stephanie ;
Geng, Xue ;
Korostyshevskiy, Valeriy ;
Karp, Judith E. ;
Lai, Catherine .
CANCER, 2023, 129 (19) :2975-2985
[50]   The effect of G-CSF on infertile women undergoing IVF treatment: A meta-analysis [J].
Li, Jie ;
Mo, Sien ;
Chen, Yang .
SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE, 2017, 63 (04) :239-247
12345